Your browser doesn't support javascript.
loading
Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO).
Rieger, C T; Liss, B; Mellinghoff, S; Buchheidt, D; Cornely, O A; Egerer, G; Heinz, W J; Hentrich, M; Maschmeyer, G; Mayer, K; Sandherr, M; Silling, G; Ullmann, A; Vehreschild, M J G T; von Lilienfeld-Toal, M; Wolf, H H; Lehners, N.
Affiliation
  • Rieger CT; Hematology and Oncology Germering, Lehrpraxis der Ludwig-Maximilians-Universität, University of Munich, Munich. Electronic address: christina.rieger@med.uni-muenchen.de.
  • Liss B; Department of Internal Medicine, Helios University Hospital Wuppertal, Wuppertal.
  • Mellinghoff S; Department I of Internal Medicine, University Hospital Cologne, Cologne; CECAD Cluster of Excellence, University of Cologne, Cologne.
  • Buchheidt D; Department of Internal Medicine - Hematology and Oncology, Mannheim University Hospital, University of Heidelberg, Heidelberg.
  • Cornely OA; Department I of Internal Medicine, University Hospital Cologne, Cologne; CECAD Cluster of Excellence, University of Cologne, Cologne; Clinical Trials Center Cologne, ZKS Köln, University Hospital of Cologne, Cologne.
  • Egerer G; Department of Hematology, University Hospital Heidelberg, Heidelberg.
  • Heinz WJ; Department of Internal Medicine II - Hematology and Oncology, University of Würzburg, Würzburg.
  • Hentrich M; Department of Hematology and Oncology, Rotkreuzklinikum München, Munich.
  • Maschmeyer G; Department of Hematology, Oncology and Palliative Care, Klinikum Ernst von Bergmann, Potsdam.
  • Mayer K; Department of Hematology and Oncology, University Hospital Bonn, Bonn.
  • Sandherr M; Hematology and Oncology, Weilheim.
  • Silling G; Department of Hematology and Oncology, University of Aachen, Aachen.
  • Ullmann A; Department of Internal Medicine II - Hematology and Oncology, University of Würzburg, Würzburg.
  • Vehreschild MJGT; Department of Internal Medicine, Helios University Hospital Wuppertal, Wuppertal.
  • von Lilienfeld-Toal M; Department of Hematology and Oncology, Internal Medicine II, University Hospital Jena, Jena.
  • Wolf HH; Department of Hematology and Oncology, University Hospital Halle, Halle.
  • Lehners N; Department of Hematology, University Hospital Heidelberg, Heidelberg; Max-Eder-Group Experimental Therapies for Hematologic Malignancies, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Ann Oncol ; 29(6): 1354-1365, 2018 06 01.
Article in En | MEDLINE | ID: mdl-29688266
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Communicable Diseases / Vaccination / Practice Guidelines as Topic / Hematologic Neoplasms / Stem Cell Transplantation / Anti-Infective Agents / Neoplasms Type of study: Etiology_studies / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2018 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Communicable Diseases / Vaccination / Practice Guidelines as Topic / Hematologic Neoplasms / Stem Cell Transplantation / Anti-Infective Agents / Neoplasms Type of study: Etiology_studies / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2018 Document type: Article Country of publication: United kingdom